Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

COVID-19 in Italy: passing through bitter waters

Lorenzo Guglielmetti, Sheila Chiesi
European Respiratory Journal 2020 56: 2001812; DOI: 10.1183/13993003.01812-2020
Lorenzo Guglielmetti
1Infectious Diseases Unit, Piacenza Hospital, Piacenza, Italy
2APHP, Sorbonne Université, Site Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France
3Sorbonne Université, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, équipe 2, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lorenzo Guglielmetti
  • For correspondence: lorenzo.guglielmetti@aphp.fr
Sheila Chiesi
4‘Spedali Civili’ Hospital of Brescia, Brescia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sheila Chiesi
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The COVID-19 epidemic in Italy has shown many shortcomings in the national healthcare system but it also represents a historic opportunity to reinforce central healthcare governance and reduce inequalities across the country https://bit.ly/3gaP9Qi

To the Editor:

The catastrophic impact of the coronavirus disease 2019 (COVID-19) epidemic in Italy has previously been described [1, 2]. In a recent editorial, Nava et al. [3] paid a well-deserved tribute to the almost 200 healthcare workers who succumbed to COVID-19 in the country in less than 3 months since the first case was reported. We would like to contribute with some considerations on the shortcomings of Italy's response to the pandemic.

Around the first COVID-19 cluster in northern Italy, between the regions of Lombardy and Emilia-Romagna, the caseload explosion has been abrupt [4]. Resources quickly became insufficient to provide adequate assistance to all patients [5] As the system became progressively overwhelmed, the death toll started to rise.

During these weeks, working among the communities paying the highest price to the epidemic, we have witnessed the relentless commitment of healthcare personnel at all levels. It has been at once moving and disheartening to observe them struggling to cope with unbearable workloads in a system that was not prepared to support them. Faced with exhausting shifts and often without adequate personal protective equipment, healthcare workers have been unsurprisingly affected by high rates of infection and death [6]. Indeed, as shown by Nava et al.[3], 65% of the casualties among medical doctors occurred in the two aforementioned regions.

Obvious reasons for Italy's inadequate outbreak response are years of public sector neglect, increased private expenditure and healthcare budget cuts by governments of all political affiliations [7]. Other major shortfalls stem, in our opinion, from the extreme regionalisation of healthcare, which has led to fragmentation of the decision-making process, increased inequalities and a lack of national coordination [8].

For instance, COVID-19 testing policies vary widely in Italy: some regions perform mass contact tracing and outreach activities, while others prioritise severely sick patients. The role of general practitioners in outbreak response activities also differs substantially across the country. This heterogeneity, coupled with ambiguous communication, has generated inefficiencies and confusion.

Resource allocation during the emergency was similarly impacted, particularly with regard to the management of intensive care unit (ICU) needs. As previously highlighted, Italy only had a modest number of ICU beds [9]. During recent years, this number has been progressively tapered due to budget necessities, despite repeated warning by experts [10]; this meant that the country was completely unprepared for a high burden of patients who required intensive support. Major differences between regions, even those neighbouring one another, in terms of respiratory equipment availability were obvious on everyday news. Nevertheless, inter-regional collaboration was limited. Most patient transfers to relieve overwhelmed ICUs were performed inside the same region, or towards foreign countries.

Finally, the lack of standardisation also affected patient management, which was guided by regional, not national, guidelines. Participation in clinical trials and access to investigational drugs were easier for bigger centres and university hospitals, where greater research experience and manpower facilitated their implementation.

To quote a famous colleague, Doctor Van Helsing from Bram Stoker's Dracula, we will have to pass through the bitter waters before reaching the sweet. Once there, though, this historic opportunity for reform should be seized: we should strengthen our public healthcare system, reinforce central governance, reduce inequalities across regions and go back to just hospitals rather than “aziende ospedaliere” (hospital companies). Only then will we be ready to react efficiently to the next pandemic threat while adequately protecting our healthcare workers [1].

Shareable PDF

Supplementary Material

This one-page PDF can be shared freely online.

Shareable PDF ERJ-01812-2020.Shareable

Footnotes

  • Conflict of interest: L. Guglielmetti has nothing to disclose.

  • Conflict of interest: S. Chiesi has nothing to disclose.

  • Received May 15, 2020.
  • Accepted May 15, 2020.
  • Copyright ©ERS 2020
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Nacoti M,
    2. Ciocca A,
    3. Giupponi A, et al.
    At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Catal 2020; https://doi.org/10.1056/CAT.20.0080.
  2. ↵
    1. Rosenbaum L
    . Facing Covid-19 in Italy – ethics, logistics, and therapeutics on the epidemic's front line. N Engl J Med 2020; 382: 1873–1875. doi:10.1056/NEJMp2005492
    OpenUrlPubMed
  3. ↵
    1. Nava S,
    2. Tonelli R,
    3. Clini E
    . An Italian sacrifice to COVID-19 epidemic. Eur Respir J 2020; 55: 2001445. doi:10.1183/13993003.01445-2020
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Remuzzi A,
    2. Remuzzi G
    . COVID-19 and Italy: what next? Lancet 2020; 395: 1225–1228. doi:10.1016/S0140-6736(20)30627-9
    OpenUrlPubMed
  5. ↵
    1. Truog RD,
    2. Mitchell C,
    3. Daley GQ
    . The toughest triage – allocating ventilators in a pandemic. N Engl J Med 2020; 382: 1973–1975.
    OpenUrlPubMed
  6. ↵
    1. Istituto Superiore di Sanità
    . Integrated surveillance of COVID-19 in Italy. https://www.epicentro.iss.it/en/coronavirus/bollettino/Infografica_4maggio%20ENG.pdf Date last updated: 13 May 2020. Date last accessed: 15 May 2020.
  7. ↵
    1. Armocida B,
    2. Formenti B,
    3. Ussai S, et al.
    The Italian health system and the COVID-19 challenge. Lancet Public Health 2020; 5: e253. doi:10.1016/S2468-2667(20)30074-8
    OpenUrlPubMed
  8. ↵
    1. Neri S
    . Economic crisis, decentralisation and health inequalities: the case of Italy. In: Tavares AI, ed. Universal Health Coverage. IntechOpen, 2019. [https://doi.org/10.5722/intechopen.89006].
  9. ↵
    1. Boccia S,
    2. Ricciardi W,
    3. Ioannidis JPA
    . What other countries can learn from Italy during the COVID-19 pandemic. JAMA Intern Med 2020; in press [https://doi.org/10.1001/jamainternmed.2020.1447].
  10. ↵
    1. Green ST,
    2. Cladi L
    . Cassandra's curse and covid-19: why do governments listen to businesses over doctors? BMJ 2020; 369: m1852.
    OpenUrlFREE Full Text
PreviousNext
Back to top
View this article with LENS
Vol 56 Issue 1 Table of Contents
European Respiratory Journal: 56 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 in Italy: passing through bitter waters
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
COVID-19 in Italy: passing through bitter waters
Lorenzo Guglielmetti, Sheila Chiesi
European Respiratory Journal Jul 2020, 56 (1) 2001812; DOI: 10.1183/13993003.01812-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
COVID-19 in Italy: passing through bitter waters
Lorenzo Guglielmetti, Sheila Chiesi
European Respiratory Journal Jul 2020, 56 (1) 2001812; DOI: 10.1183/13993003.01812-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Agora

Correspondence

  • Endothelial to mesenchymal transition as novel feature of pulmonary fibrosis
  • Transitioning endothelial cells contribute to pulmonary fibrosis
  • Treatable traits in ILD: why not consider acute exacerbations?
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society